GUTS Q2 2023 Earnings — Fractyl Health, Inc. Common Stock Revenue & Financial Results | Market Cap Arena

GUTSFractyl Health, Inc. Common Stock

$35M

Q2 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$72,000

Gross Profit

$25,00034.7% margin

Operating Income

-$12M-16493.1% margin

Net Income

-$30M-41988.9% margin

EPS (Diluted)

$-0.63

QoQ Revenue Growth

+1340.0%

Cash Flow

Operating Cash Flow

-$12M

Free Cash Flow

-$12M

Stock-Based Comp.

$1M

Balance Sheet

Total Assets

$39M

Total Liabilities

$331M

Stockholders' Equity

-$293M

Cash & Equivalents

$28M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$72,000	$0	—
Gross Profit	$25,000	$0	—
Operating Income	-$12M	-$13M	+10.1%
Net Income	-$30M	-$12M	-146.5%